Daily non-political popular news in brief.
Pancreatic cancer surgery 5-year survivors 65 and up live nearly as long as anyone
01-09-2007 · EurekAlert!Pancreatic cancer patients 65 or older who live five years after surgery have nearly as good a chance as anyone to live another five years. Researchers reviewed records of 890 pancreatic cancer patients who over a 30 year-period underwent surgery. They found 23 percent lived five years after surgery, half of whom were 65 or older. Some 65 percent lived another five years compared to 87 percent in the general population at age 70.
Read more »
Keywords: pancreatic, cancer, surgery, 5-year, survivors, live, nearly, anyone, year, survivor
« Previous | Next »
Similar news on "Pancreatic cancer surgery 5-year survivors 65 and up live nearly as long as anyone":
- New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
08-29-2007 · UT Southwestern Medical Center
Michael Yarborough, a 58-year-old business owner from Waxahachie, Texas, was fortunate. A routine check-up three years ago revealed prostate cancer, but a side effect of his successful surgery was "driving him nuts."
Similar news · Read more »
- Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
06-22-2007 · EurekAlert!
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Similar news · Read more »
- Radiation after surgery doubles survival time for some lung cancer patients
11-06-2006 · EurekAlert!
Patients with lung cancer that has spread to mediastinal lymph nodes -- located between the chest, breastbone and spine -- who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- New tumour markers -- 'Spot the differences'
06-20-2007 · EurekAlert!
Pancreatic cancer (PC), the subject of this thesis, has the poorest prognosis of all cancers: the survival rate after five years with the disease is less than five percent and on average, patients who have been diagnosed with it do not live longer than six months.
Similar news · Read more »
- Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
11-09-2007 · EurekAlert!
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team’s analysis of several trial results.
Similar news · Read more »
- Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
09-27-2007 · EurekAlert!
Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists.
Similar news · Read more »
- Adult Survivors Of Childhood Cancer Face Long-term Health Problems
10-14-2006 · ScienceDaily
Survivors of childhood cancer may face long-term health problems well into adulthood, as reported in a multicenter study of over 10,000 adults who survived a childhood battle with cancer. One of the co-authors of the Childhood Cancer Survivor Study is a long-standing pioneer in the field. Anna T. Meadows, M.D., and colleagues at the Children's Hospital of Philadelphia were the first researchers to investigate the late effects of childhood cancer, starting in the mid-1970s.
Similar news · Read more »
- Chemotherapy appears to delay cancer recurrence following surgery for pancreatic cancer
01-16-2007 · EurekAlert!
Use of the drug gemcitabine for chemotherapy significantly delays the recurrence of cancer, compared to no chemotherapy, for patients following pancreatic cancer surgery, according to a study in the January 17 issue of JAMA.
Similar news · Read more »
- A close-up on pancreatic disease: How do we improve the odds?
05-22-2007 · EurekAlert!
Pancreatic cancer is among the deadliest of today's cancers due to limited tools for early diagnosis and few effective treatments. Research presented today at Digestive Disease WeekпїЅ 2007 takes a closer look at pancreatic cancer and the conditions that may lead to it, such as chronic pancreatitis, to evaluate the progress made to date, as well as the promising new applications of technology that will improve survival rates in the coming years. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Similar news · Read more »
- More than 6 months of hormone therapy doesn't help prostate cancer patients live longer
11-05-2006 · EurekAlert!
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
